SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Arunkanth Ankala, Parag M. Tamhankar, C. Alexander Valencia, Krishna K. Rayam, Manisha M. Kumar, Madhuri R. Hegde, Clinical Applications and Implications of Common and Founder Mutations in Indian Subpopulations, Human Mutation, 2015, 36, 1
  2. 2
    E. Gouider, S. Rauchensteiner, T. Andreeva, A. Al Zoebie, S. Mehadzic, L. Nefyodova, M. Brunn, C. Tueckmantel, B. Meddeb, Real-life evidence in evaluating effectiveness of treatment in Haemophilia A with a recombinant FVIII concentrate: A non-interventional study in emerging countries, Haemophilia, 2015, 21, 2
  3. 3
    A. M. Carvalhosa, S. Henrard, C. Lambert, C. Hermans, Physical and mental quality of life in adult patients with haemophilia in Belgium: the impact of financial issues, Haemophilia, 2014, 20, 4
  4. 4
    Steven R Lentz, Stephanie Seremetis, Janice Staber, Roshni Kulkarni, Turoctocog alfa and drug development for hemophilia A, Expert Opinion on Orphan Drugs, 2014, 2, 4, 419

    CrossRef

  5. 5
    J.A. Finn, G.N. Vyas, Pathobiology of Human Disease, 2014,

    CrossRef

  6. 6
    H. J. Metzner, S. W. Pipe, T. Weimer, S. Schulte, Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albumin, Thrombosis and Haemostasis, 2013, 110, 5, 931

    CrossRef

  7. 7
    B. O'Mahony, D. Noone, P. L. F. Giangrande, L. Prihodova, Haemophilia care in Europe – a survey of 35 countries, Haemophilia, 2013, 19, 4
  8. 8
    Tsu-Chiang Tu, Wen-Shyong Liou, Tsui-Yun Chou, Tsung-Kun Lin, Chuan-Fang Lee, Jye-Daa Chen, Thau-Ming Cham, Mei-Ing Chung, Prevalence, Incidence, and Factor Concentrate Usage Trends of Hemophiliacs in Taiwan, Yonsei Medical Journal, 2013, 54, 1, 71

    CrossRef

  9. 9
    Jeffrey S. Stonebraker, Product-Generation Transition Decision Making for Bayer's Hemophilia Drugs: Global Capacity Expansion Under Uncertainty with Supply-Demand Imbalances, Operations Research, 2013, 61, 5, 1119

    CrossRef

  10. 10
    E. Carlos Rodriguez-Merchan, Differing approaches to diagnosis and treatment of musculoskeletal complications of haemophilia in resource-rich and resource-limited settings, Blood Coagulation & Fibrinolysis, 2012, 23, 7, 575

    CrossRef

  11. 11
    W. Schramm, A. Gringeri, R. Ljung, K. Berger, A. Crispin, M. Bullinger, P. L. F. Giangrande, S. Mackensen, L. G. Mantovani, L. Nemes, M. Serban, Haemophilia Care in Europe: the ESCHQoL study, Haemophilia, 2012, 18, 5
  12. 12
    A. FARRUGIA, B. O’MAHONY, J. CASSAR, Health technology assessment and haemophilia, Haemophilia, 2012, 18, 2
  13. 13
    Nathalia Gonsales da Rosa, Kamilla Swiech, Virgínia Picanço-Castro, Elisa Maria de Sousa Russo-Carbolante, Mario Abreu Soares Neto, Andrielle de Castilho-Fernandes, Vitor Marcel Faça, Aparecida Maria Fontes, Dimas Tadeu Covas, SK-HEP cells and lentiviral vector for production of human recombinant factor VIII, Biotechnology Letters, 2012, 34, 8, 1435

    CrossRef

  14. You have free access to this content14
    Steven W. Pipe, The hope and reality of long-acting hemophilia products, American Journal of Hematology, 2012, 87, S1
  15. 15
    S. DHARMARAJAN, P. GUND, S. PHADNIS, S. LOHADE, A. LALWANI, A. KAR, Treatment decisions and usage of clotting factor concentrate by a cohort of Indian haemophilia patients, Haemophilia, 2012, 18, 1
  16. 16
    J. S. STONEBRAKER, P. H. B. BOLTON-MAGGS, M. BROOKER, A. FARRUGIA, A. SRIVASTAVA, A study of reported factor IX use around the world, Haemophilia, 2011, 17, 3
  17. 17
    A. Giampaolo, F. Abbonizio, M. Puopolo, R. Arcieri, P. M. Mannucci, H. J. Hassan, Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy, Transfusion Medicine, 2011, 21, 4
  18. 18
    B. O’MAHONY, D. NOONE, P. L. F. GIANGRANDE, L. PRIHODOVA, Haemophilia care in Europe: a survey of 19 countries, Haemophilia, 2011, 17, 1
  19. You have free access to this content19
    Mark W. Skinner, Haemophilia: provision of factors and novel therapies: World Federation of Hemophilia goals and achievements, British Journal of Haematology, 2011, 154, 6
  20. 20
    M. SKINNER, A. STREET, Global data and haemophilia care trends: commentary, Haemophilia, 2010, 16, 1
  21. 21
    Sami Chtourou, Production and Clinical Profile of Human Plasma Coagulation Factor VIII,
  22. 22
    Antonio Coppola, Matteo Nicola Dario Di Minno, Jerzy Windyga, Treatment for preventing bleeding in people with congenital bleeding disorders undergoing surgery, The Cochrane Library,
  23. 23
    Antonio Coppola, Jerzy Windyga, Antonella Tufano, Cindy Yeung, Matteo Nicola Dario Di Minno, Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery, The Cochrane Library,